Navigation Links
Justice Department Reaches Settlement Agreement With Medical Weight Loss Clinic
Date:7/8/2008

WASHINGTON, July 8 /PRNewswire-USNewswire/ -- The Justice Department today announced that it has reached a settlement with the Medical Weight Loss Clinic, which is headquartered in Southfield, Mich., under the Americans with Disabilities Act (ADA). It was alleged that Medical Weight Loss Clinic refused to serve a prospective client because she has HIV disease.

Under the terms of today's agreement, Medical Weight Loss Clinic will provide training on the non-discrimination provisions of the ADA generally and as they relate to individuals with HIV disease, and will adopt and post at each of its 34 locations a nondiscrimination policy and procedure. Medical Weight Loss Clinic will also pay the complainant $20,000 in damages.

"Health-related services must be provided in a non-discriminatory manner to all persons who need them," said Grace Chung Becker, Acting Assistant Attorney General for the Civil Rights Division. "The Justice Department is committed to ensuring that public accommodations do not discriminate against individuals with disabilities, including those with HIV disease."

"When we are dealing with people's health needs, whether the issue is weight loss or some other health matter, discrimination against those who are sick or who are HIV positive simply cannot be permitted," said Stephen J. Murphy, U.S. Attorney for the Eastern District of Michigan. "We must ensure that access to health-related services is not barred due to this type of unlawful discrimination. Today's settlement is a good step in that direction."

Title III of the ADA prohibits public accommodations, such as Medical Weight Loss Clinic, from discriminating against any individual on the basis of disability with respect to the goods, services, facilities and privileges of the public accommodation. Those interested in finding out more about the ADA or the agreement can call the Justice Department's toll-free ADA Information Line at (800) 514-0301 or (800) 514-
'/>"/>

SOURCE U.S. Department of Justice
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Justice Department Reaches Settlement to Improve Conditions at a Nebraska Developmental Center
2. Fact Sheet: Department of Justice Efforts to Combat Health Care Fraud and Abuse
3. Prepared Remarks of Attorney General Michael B. Mukasey on the Justice Departments Efforts to Combat Healthcare Fraud Nationwide
4. $10,000 Offer to National RTL From American RTL to Name One Pro-Life Justice
5. Premier issue of Environmental Justice just published
6. Leiner Health Products Submits Proposed Agreement with Department of Justice to U.S. Bankruptcy Court for Approval
7. Legal Aid Provides Access to Justice for Victims of Violent Crime
8. Thomas Farina, Former Pharmaceutical Company District Manager, Charged With Obstruction of Justice
9. Justice Department Requires Divestiture in UnitedHealth Groups Acquisition of Sierra Health Services
10. Mental health screenings, risk behavior interventions needed in juvenile justice system
11. Justice Department Requires Divestitures in Pearsons Acquisition of Harcourt Assessment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/6/2008)...t. 6 /PRNewswire/ -- Developed in collaboration wi...ades, CA is introducing,Revolutionary Breast Surfa...c Surgery office of Dr. Steve Laverson this week i...he first of its kind, and is based on,breakthrough...with,innovative proprietary software. The XS-300(T...
(Date:10/6/2008)...ct. 6 /PRNewswire/ -- The organizers of Informex a...e on Global Sourcing for the,Pharmaceutical Indust...inceton Marriott in New Jersey USA., The conferen... the,Global Sourcing Council, and boasts an unpara...e likes of Johnson & Johnson, Bristol Myers Squibb...
(Date:10/6/2008)... LegalView recently posted detailed inform...he potentially serious side effects caused by the ... the drug,s potential side effects are the develop... for young adult and child patients. , ...- LegalView, the number one resource for everythin...
(Date:10/6/2008)... Hospital Ship Serving in West Africa Rece...Garden Valley, Texas October 6, 2008 -- www.seamob...l provider of communications services to remote lo...s to the FoxNews channel via satellite to Mercy Sh...ica Mercy. The Africa Mercy is the world,s larges...
Breaking Medicine News(10 mins):Health News:Plan Your Breasts in 3-D 2Health News:Global Sourcing Strategies for the Pharmaceutical Industry 10th - 11th November, Marriott Princeton, New Jersey USA 2Health News:LegalView Informs Patients of Possible Cimzia Cancer Link, Drug Commonly Used to Treat Arthritis 2Health News:LegalView Informs Patients of Possible Cimzia Cancer Link, Drug Commonly Used to Treat Arthritis 3Health News:Seamobile Provides Foxnews To Mercy Ships 2Health News:Seamobile Provides Foxnews To Mercy Ships 3
...w South Wales may be one of the first scientists t...bipolar disease. Currently there is no single test...searchers who had their paper published in the lat...Research said that this may make the diagnosis of ...
...bidity and mortality in India. An attempt to formu...h has claimed so many young lives, is worth the ex...l trials of a new vaccine for a deadly form of dia...ths annually in India. This move has been accelera...
... system that ranks foods according to the sum of t...ped// by a panel of independent nutritionists, die...y and consumer groups, as well as members of the g...e on Nutrition (SACN). The model developed by th...
...he smoking pot and cigar of the 70s. If you want t...le, just stay on your cell phone and check your e-...n. A study commissioned by Hewlett-Packard shows t...logy, including e-mail and cell phones, can be sli...
Other Medicine News:Health News:Schizophrenia Gets A New Diagnostic Tool 2Health News:Nutrient Profiling System Launched By Food Officials in UK 2Health News:E-Mail Affects Brain More Than Marijuana 2
(Date:10/6/2008)...ay Eliminate 6 Weeks of Radiation Therapy -, Event...nternet Wednesday, October 22, 2008, 3 - 4 p.m.... , HAMPTON, Va., Oct. 6 / Questions ...sed with breast cancer in May. Would she have the,...ation or chemotherapy?, , To view the Multimedia...
(Date:10/3/2008)... Jersey is the newest study site, PHILADELPHIA, O...spital,of Philadelphia today received a contract t...,s Study. Children,s Hospital will manage local,pa...rlington County, New,Jersey. The study is funded b...rs anticipate approximately 1,000 families in Burl...
(Date:10/2/2008)...the Results of Rosetta Genomics, microRNA-based,Te...amous From non Squamous non Small Cell Lung C...ed on the miRview(TM) Technology First Approved fo...gh Complexity Molecular Pathology Lab ... is Expecting to Launch miRview(TM) Squamous Later...
(Date:10/2/2008)...RNewswire-FirstCall/ - AEterna Zentaris Inc.,(NASD...company focused on,endocrine therapy and oncology,...ge of patient recruitment for its Phase 2 trial in...ne-releasing hormone (LHRH) agonist,linked to doxo... patient,recruitment was taken following recent fi...
Breaking Medicine Technology:Photos: Sentara Joins 4 U.S. Hospitals in International 'TARGIT' Breast Cancer Trial 2The Children's Hospital of Philadelphia Announces New Regional Participant in The National Children's Study 2Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay 2Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay 3Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay 4Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay 5AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Ovarian Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 2AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Ovarian Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 3AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Ovarian Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 4AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Ovarian Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 5Evotec Expands Collaboration With InterMune 3744 1Evotec Expands Collaboration With InterMune 3744 2Evotec Expands Collaboration With InterMune 3744 3High levels of estrogen associated with breast cancer recurrence 2422 1High levels of estrogen associated with breast cancer recurrence 2422 2Secrets of cooperation between trees and fungi revealed 2419 1Secrets of cooperation between trees and fungi revealed 2419 2AHIP Statement on House Passage of Mental Health Parity Legislation 13613 1
...,s Oncology Group (COG) Study Presented at,America...HICAGO, June 04, 2007 /PRNewswire-FirstCall/ -- Im...used on developing monoclonal,antibodies to treat ... that treatment with epratuzumab plus standard,che...en with,B-precursor acute lymphoblastic leukemia (...
...t analyses of progression-free survival in,the SPA...ion in,relative risk of disease progression for pa...ded prior Taxotere use,geographies, as well as pr... /PRNewswire-FirstCall/ -- Pharmion,Corporation an...of,additional data from the double-blind, randomiz...
Other Medicine Technology:Promising Results with Epratuzumab and Chemotherapy in Children,with Acute Lymphoblastic Leukemia 2Promising Results with Epratuzumab and Chemotherapy in Children,with Acute Lymphoblastic Leukemia 3Promising Results with Epratuzumab and Chemotherapy in Children,with Acute Lymphoblastic Leukemia 4Promising Results with Epratuzumab and Chemotherapy in Children,with Acute Lymphoblastic Leukemia 5Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 2Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 3Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 4Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 5Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 6Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 7
9" X 14" translucent plastic may be used with illuminated test cabinet or as a wall chart 20/200 to 20/15.
...cally priced 2-channel data acquisition system sui...of human and animal physiology, pharmacology, neur...omedical engineering. The PowerLab 2/25 supports a...rs. Two Pod ports are featured allowing direct con...
...formance recording unit suitable for a wide range ... up to 16 input channels. Examples include sleep, ...nit is capable of recording at speeds of up to 200...is compatible with instruments, signal conditioner...
...ormance data acquisition system suitable for a wid...nd animal physiology, pharmacology, neurophysiolog...engineering. The unit is capable of recording from...les per second continuously to disk), and is compa...
Medicine Products: